Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.
Ring Therapeutics has raised $86.5M in total funding. The most recent round was Series C. The last funding was announced in March 2023.
Ring Therapeutics's investors include Flagship Pioneering, Alexandria Venture Investments, Invus, T. Rowe Price, Partners Investment.
Ring Therapeutics is headquartered in Cambridge, United States.
Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.
Ring Therapeutics is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ring Therapeutics — Funding & Investors." VCBacked, March 9, 2023, https://www.vcbacked.co/company/ring-therapeutics. Accessed August 14, 2026.
VCBacked. (2023). Ring Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/ring-therapeutics
{{cite web |title=Ring Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ring-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated